THE OTHER PATH · THE EVIDENCE BEHIND THE SHELVES
Research
Good questions. Thoughtful choices.
Why CBN for an evening routine? Why CBD? Why choose a tincture or a topical? Here is a plain-language look at the research behind those conversations, including where the science is promising and where we are still learning.
Research reviewed November 12, 2026 · For adults 21+
EARLY HUMAN EVIDENCE
CBN & sleep: why the interest?
CBN is being studied for sleep continuity: staying asleep and experiencing fewer interruptions. That is a more specific question than whether something simply makes you feel sleepy.
A placebo-controlled trial published in 2024 analyzed 293 adults with poor sleep. Taking 20 mg of CBN nightly for seven nights reduced reported awakenings and overall sleep disturbance. The main sleep-quality outcome did not reach statistical significance, and falling asleep faster was not demonstrated. Adding CBD did not improve the CBN results. The authors were affiliated with cannabinoid companies, a useful consideration when weighing the findings. Read the 2024 CBN trial ↗
A 2026 overnight crossover trial in 20 adults with diagnosed insomnia tested 30 mg and 300 mg of CBN. Neither dose significantly improved the primary measure of time awake after initially falling asleep. The 300 mg dose improved some secondary measures, including time to fall asleep and perceived sleep quality. This small, single-night study does not establish a long-term treatment. Read the 2026 insomnia trial ↗
CBN belongs in an informed conversation about evening routines because there are encouraging human findings. Calling it a proven sleep aid goes beyond the evidence. Compare the amount of CBN per serving, rather than total cannabinoids per bottle. Study amounts are context, not suggested doses. Persistent insomnia deserves a conversation with a clinician.
PROMISING, MIXED HUMAN FINDINGS
CBD & anxiety: a reason for curiosity
Small studies suggest CBD can influence the response to stressful situations. In a 2011 randomized experiment, 24 people with social anxiety received either 600 mg CBD or placebo before simulated public speaking. The CBD group reported less anxiety during the task. A single stressful event in a small group is different from treating an anxiety disorder over time. Read the public-speaking trial ↗
A 2024 trial in 50 women with advanced breast cancer tested 400 mg of oral CBD before a scan. The main comparison of change in anxiety did not show a significant benefit; an exploratory comparison of anxiety after dosing favored CBD. This is a signal worth investigating, with important limitations. Read the scan-anxiety trial ↗
CBD is an ingredient some adults choose to explore as part of a calming routine. “Great for anxiety” is too broad a conclusion from these studies. Their formulations and often much larger amounts cannot be assumed equivalent to a serving of a retail gummy or tincture. CBD should not replace established mental-health care or prescribed medication.
LABORATORY RATIONALE · CLINICAL UNCERTAINTY
CBD & inflammation: from the lab to real life
Inflammation is an immune response; pain is a sensation. They can overlap, but improvement in one does not prove improvement in the other. Researchers have found that CBD changes inflammatory signaling in laboratory models. For example, a 2020 study of cells from rheumatoid joints found effects on cell activity and inflammatory mediators. Those cells were studied outside the body, not as a treatment in patients. Read the joint-cell study ↗
The human picture is less certain. In a trial of 136 people with hand osteoarthritis or psoriatic arthritis, oral CBD at 20–30 mg daily for 12 weeks did not improve pain compared with placebo. This trial does not answer every question about inflammation, but it shows why a plausible mechanism is not enough to promise relief. Read the arthritis trial ↗
The inflammation research helps explain the scientific interest in CBD. It does not establish that a shop product treats arthritis, reduces inflammation throughout the body, or repairs an injury. We help you distinguish ingredient research, comfort preferences, and medical treatment.
COMPOSITION FIRST · CLAIMS SECOND
Full spectrum vs. broad spectrum
“Spectrum” describes the mix of plant compounds in a CBD extract. It does not tell you the CBD amount per serving, whether a product will work for you, or whether it is better for sleep, anxiety, or discomfort. These terms are commonly used on labels, but the actual formula and batch-specific test results matter most.
| Question | Full spectrum | Broad spectrum |
|---|---|---|
| What is in it? | CBD with a wider range of naturally occurring cannabinoids and other plant compounds. It generally includes trace THC. | CBD with other cannabinoids and plant compounds, processed to remove THC to nondetectable levels. |
| Is every formula the same? | No. The amounts of minor cannabinoids and terpenes vary by extract and product. | No. Processing can change the profile, and not every minor cannabinoid or terpene will remain. |
| Does the name prove better results? | No. A broader profile is not clinical proof that a finished product works better. | No. The label alone does not establish effectiveness or safety. |
For comparison, CBD isolate is highly purified CBD rather than a deliberately wider cannabinoid profile. A finished product can also contain added cannabinoids or botanical ingredients, so read the complete ingredient list. Read the definitions and product-testing study ↗
What about the “entourage effect”?
The idea is that compounds in an extract may interact and change its effects. That is a research question, not a guarantee that full spectrum outperforms broad spectrum or isolate. A 2022 open-label trial of commercial CBD products did not establish a conclusive difference between spectra. Products also differed in dose and format, and the study was not designed to isolate spectrum as the deciding factor. Read the commercial-product trial and its limitations ↗
A 2023 comparison found differences in CBD absorption between certain extracts in rats. An animal absorption result is not evidence that one spectrum provides better symptom relief in people. The formulation and delivery method still matter. Read the animal pharmacokinetic study ↗
Read the lab report, not just the front label
A 2024 analysis of 202 commercial CBD products found mismatches between some spectrum claims and measured cannabinoid profiles. This market sample was not a test of TOP's current inventory. It illustrates why a label should be checked against a certificate of analysis (COA) for the finished product and its batch. Read the label-accuracy study ↗
- Match the product name and batch or lot number to the report.
- Compare CBD per serving with total CBD per bottle; they are different measurements.
- Look at the amounts of the minor cannabinoids that matter to your choice.
- “Nondetectable” means below that laboratory method's detection limit, not an absolute guarantee of zero. Check the report's limits and contaminant-testing results.
We help you compare the actual profile, format, ingredient list, and lab results. Full spectrum offers a less selectively refined profile; broad spectrum offers a selectively refined profile that retains multiple plant compounds. Neither name earns an automatic ranking for quality, safety, or benefit. Tell us your ingredient preferences, and we can help you read the specific label and request its lab report.
THE DELIVERY METHOD MATTERS
Tinctures & vapes: what changes with the format?
An oral tincture avoids breathing a heated aerosol into the lungs. It also lets you measure a liquid serving and check milligrams per milliliter. Those are practical reasons to consider it when you want an inhalation-free routine.
| Question | Oral oils / tinctures | Vaping |
|---|---|---|
| What is exposed? | The mouth and digestive tract; absorbed CBD is processed by the body. | The respiratory tract is exposed to aerosol and substances produced during heating. |
| Can you measure a serving? | A marked dropper and a clear concentration help measure the intended amount. | Delivered amounts vary with the device, formulation, and puffing pattern. |
| Is it automatically safer or more effective? | No. Avoiding aerosol is an advantage for lung exposure, but oral CBD can still cause interactions and adverse effects. | A faster route is not proof of better treatment, and long-term safety depends on more than the ingredient name. |
CBD-aerosol research in mice and human cell models found inflammatory and injury-related changes in the lungs. It raises a reason for caution, but does not measure the exact risk to a person using a particular device. Read the inhalation study ↗
“Under the tongue” also does not guarantee superior absorption. A randomized crossover study in eight men found similar blood CBD profiles from sublingual oil drops and swallowed capsules. Some oil may be swallowed before meaningful mouth absorption occurs. A formulation's absorption data should not be confused with proof that it works better for a symptom. Read the drops-versus-capsules study ↗
We carry tinctures as a measurable, inhalation-free option. We do not present them as universally more effective, risk-free, or interchangeable with other formats. Use oils only by the route on their label; an oral oil is not a vape liquid.
LOCAL APPLICATION · FORMULA-SPECIFIC EVIDENCE
How CBD & herbal topicals work
A cream or balm puts ingredients on the skin where you apply it. The skin is also a barrier: concentration, the cream or oil base, and penetration-enhancing ingredients affect how much gets through. A topical is not automatically a transdermal product designed for delivery into the bloodstream. In a 46-person study of five commercial CBD topicals, measurable absorption occurred with some formulations, demonstrating that products can behave differently. Read the topical absorption study ↗
CBD: encouraging small trials
A 2022 crossover trial in 18 people with thumb-base arthritis found better reported pain and disability with a specific CBD-and-shea-butter formulation than with shea butter alone. Grip and pinch strength did not differ. This short, small study supports more research; it does not validate every CBD lotion, balm, or patch. Read the topical CBD trial ↗
The other ingredients matter, too
Menthol creates a cooling sensation and can change the perception of discomfort. A small placebo-controlled crossover trial in 10 workers with carpal-tunnel symptoms found short-term pain improvement with menthol gel. The result is limited and does not prove nerve healing or that CBD caused relief in a combined formula. Read the menthol trial ↗
Arnica and calendula need their own evidence. A 204-person trial found a particular arnica gel performed similarly to ibuprofen gel for hand-arthritis symptoms over three weeks; it lacked a placebo comparison. A review of calendula trials found only weak evidence for wound healing. Neither finding can be transferred to every herbal balm or scented lotion. Check whether these ingredients are actually present and in what preparation. Arnica trial ↗ · Calendula evidence review ↗
TOP's catalog includes NuBloom (Chil Wellness) Pain & Recovery Lotion, Kush Queen Melt CBD Lotion, CBDfx Muscle and Joint cream, and a Medterra Menthol Roll-On listing. These are examples of different topical formats, not the formulas tested in the studies above. Names, formulas, and availability can change; the current package and ingredient list are the reference. A cooling or warming sensation alone does not demonstrate an anti-inflammatory effect.
Use only as directed, avoid eyes and broken skin unless the label specifically permits use, and stop if irritation develops. Do not add a heating pad to a warming or cooling topical. See current product labels in the shop →
MORE INGREDIENTS, DIFFERENT QUESTIONS
Other botanical paths we follow
Kava
Studied for anxiety, with mixed findings. A 16-week trial in 171 people with generalized anxiety did not show superiority over placebo. A social drink is not equivalent to the standardized extract studied. Read the trial ↗ Kava can cause sedation and has been associated with rare, serious liver injury; avoid combining it with alcohol or sedatives. NIH safety guidance ↗
Kanna
A small brain-imaging study in 16 healthy people found that a standardized kanna extract changed responses to emotional stimuli. This is a possible mechanism, not proof of treatment for anxiety or depression. Gummies, drinks, and different extracts cannot be assumed equivalent. Read the imaging study ↗
Lion's mane
A 41-person pilot trial found improvement on one cognitive task, alongside null and some negative findings. A stress-reduction trend did not meet the usual significance threshold. Interesting early research does not establish a general memory or mood benefit for mushroom blends. Read the pilot trial ↗
These ingredients have different traditions, compounds, and research histories. A study of one extract cannot establish the benefits or safety of a multi-ingredient drink or chocolate.